| Red Hawk Mining Limited (RHK) ORDINARY FULLY PAID |
Materials |
$254 |
Ceasing to be a substantial holder
|
26 Feb 2025 9:16AM |
$1.200 |
$1.200 |
fallen by
0%
|
|
| Freelancer Limited (FLN) ORDINARY FULLY PAID |
Industrials |
$81 |
2024 Results Commentary
|
26 Feb 2025 9:16AM |
$0.160 |
$0.180 |
risen by
12.50%
|
|
FLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Group GMV of $948.6 million, down 7.1% vs. FY23
- Group revenue of $53.1 million, down 4.2%
- New client deposits up 18.6% year-on-year in 4Q24
- Operating cash flow of $5.8 million, compared to $1.9 million in FY23
- Operating costs reduced by 5.8% compared to FY23
- Cash reserves of $23.2 million, up 9.5% from 1H24
- Freelancer achieved a turnaround in customer acquisition
- AI integration contributed to improved marketplace features
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EDU Holdings Limited (EDU) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
2024 - Results Announcement
|
26 Feb 2025 9:15AM |
$0.145 |
$0.170 |
risen by
17.24%
|
|
EDU - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 96% to $42.3 million.
- Return to profitability with a net profit of $2.6 million.
- EBITDA margin improved to 19%.
- Strategic entry into postgraduate market with new programs.
- Strong cashflow generation with $6.5 million cash at bank.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freelancer Limited (FLN) ORDINARY FULLY PAID |
Industrials |
$81 |
2024 Financial and Directors Report
|
26 Feb 2025 9:15AM |
$0.160 |
$0.180 |
risen by
12.50%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$51 |
H1 FY25 Results Presentation
|
26 Feb 2025 9:15AM |
$0.051 |
$0.044 |
fallen by
13.73%
|
|
PPL - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY25 revenue of $29.2 million represents a 22% increase compared to H1 FY24.
- EBITDA rose 38% to $3.3 million, marking a record half-year performance.
- Net profit after tax for H1 FY25 was $1.6 million, significantly up from $4,000 in the previous year.
- Revenue growth attributed to strong performance in both ANZ and international markets.
- Focus on leveraging AI technologies for client-facing solutions and enhancing operational efficiencies.
- Financial guidance for FY25 upgraded based on strong trading performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$32 |
Application for quotation of securities - GTI
|
26 Feb 2025 9:15AM |
$0.100 |
$0.094 |
fallen by
6%
|
|
| Iron Road Limited (IRD) ORDINARY FULLY PAID |
Materials |
$31 |
Update - Notification of buy-back - IRD
|
26 Feb 2025 9:15AM |
$0.055 |
$0.037 |
fallen by
32.73%
|
|
| Legacy Minerals Holdings Limited (LGM) ORDINARY FULLY PAID |
Materials |
$26 |
Portfolio Exploration Update
|
26 Feb 2025 9:15AM |
$0.160 |
$0.205 |
risen by
28.13%
|
|
| Province Resources Ltd (PRL) ORDINARY FULLY PAID |
Materials |
$48 |
Final Director's Interest Notice
|
26 Feb 2025 9:14AM |
$0.041 |
$0.041 |
fallen by
0%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$51 |
Appendix 4D and Half Year Report
|
26 Feb 2025 9:14AM |
$0.051 |
$0.044 |
fallen by
13.73%
|
|
PPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 21.5% to $29.2 million.
- EBITDA rose by 38% to $3.3 million.
- Net profit after tax reached $1.59 million.
- Acquisition of i-Link Research Solutions enhanced market share.
- Company focused on innovation and international growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freelancer Limited (FLN) ORDINARY FULLY PAID |
Industrials |
$81 |
Appendix 4E
|
26 Feb 2025 9:14AM |
$0.160 |
$0.180 |
risen by
12.50%
|
|
FLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues decreased by 4.2% to $53,104,000 for the year ended 31 December 2024.
- The company recorded a loss of $814,000 compared to a profit of $189,000 in the previous year.
- No dividends were declared for the reporting period.
- Net tangible assets per security dropped to (3.56) cents from (3.40) cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helloworld Travel Limited (HLO) ORDINARY FULLY PAID |
Consumer Discretionary |
$256 |
HLO ASX Announcement Half Year Results 2025
|
26 Feb 2025 9:14AM |
$2.050 |
$1.570 |
fallen by
23.41%
|
|
HLO - Price-sensitive ASX Announcement
Full Release
Key Points
- Helloworld Travel Limited announced its half-year results for 2025.
- The company reported significant revenue growth compared to the previous year.
- Profitability metrics showed improvement despite market challenges.
- Operational updates indicate expansion in service offerings.
- Strategic initiatives were outlined to enhance customer experience.
- The outlook for the travel industry remains cautiously optimistic.
- Future guidance was provided for stakeholders and investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| White Energy Company Limited (WEC) ORDINARY FULLY PAID |
Energy |
$9 |
Proposed issue of securities - WEC
|
26 Feb 2025 9:14AM |
$0.028 |
$0.028 |
fallen by
0%
|
|
| Cettire Limited (CTT) ORDINARY FULLY PAID |
Consumer Discretionary |
$210 |
H1 FY25 Results Presentation
|
26 Feb 2025 9:13AM |
$1.175 |
$0.550 |
fallen by
53.19%
|
|
CTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Cettire reported a 12% increase in gross revenue to $514.1 million in H1 FY25.
- Sales revenue increased by 11% to $394 million in H1 FY25 compared to H1 FY24.
- Active customers grew by 21% to 695,000 in H1 FY25.
- Gross revenues from repeat customers increased by 29% year-on-year.
- Cettire maintained a net cash position of $101 million with zero debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helloworld Travel Limited (HLO) ORDINARY FULLY PAID |
Consumer Discretionary |
$256 |
HLO Appendix 4D Half Year 2025
|
26 Feb 2025 9:13AM |
$2.050 |
$1.570 |
fallen by
23.41%
|
|
HLO - Price-sensitive ASX Announcement
Full Release
Key Points
- Total transaction value decreased by 6.9% to $2,050 million.
- Total revenue and other income fell by 7.6% to $103.8 million.
- Underlying EBITDA decreased by 20.2% to $27.2 million.
- Profit before income tax declined by 27.1% to $17.2 million.
- Profit after income tax attributable to shareholders decreased by 28.2% to $11.5 million.
- Basic and diluted earnings per share dropped by 29.7% to 7.1 cents.
- Interim dividend declared at 8.0 cents per share, a 60% increase from the previous year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$74 |
Appendix 4D & FY25 Interim Report
|
26 Feb 2025 9:13AM |
$0.240 |
$0.165 |
fallen by
31.25%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY25 revenue of $8.08 million, up 147% from the previous period.
- MetaXplore sales in Australia increased significantly, with 4,400 tests sold in H1 FY25.
- The net loss before income tax was $5.74 million, down 50% from the previous year.
- MAP 315 is advancing towards a Phase 2 clinical trial for Inflammatory Bowel Disease.
- The company has $17.3 million in cash and equivalents as of 31 December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$197 |
Dividend/Distribution - NZM
|
26 Feb 2025 9:13AM |
$0.970 |
$1.050 |
risen by
8.25%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$36 |
Presentation Half- Year Financial Report
|
26 Feb 2025 9:13AM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Balance sheet strengthened
- Completed a successful capital raise
- Global sales rose 39% in constant currency
- Sales growth was temporarily impacted by supply chain challenges
- Sales in January 2025 were approximately 25% higher than January 2024
- Glaucoma division expected to be profitable in H2 FY25
- Projected revenue of US$9 million to US$10 million in H2 FY25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$6,878 |
Notification of buy-back - WOR
|
26 Feb 2025 9:12AM |
$14.020 |
$13.000 |
fallen by
7.28%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$36 |
Half-Year Report Release
|
26 Feb 2025 9:12AM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of US$8.5 million, up 27% YoY.
- 12-month sales totalled US$16.9 million.
- Revenue guidance for H2 FY25 expected between US$9 million and US$10 million.
- Glaucoma division EBITDA loss of US$1.8 million.
- iTrack™ Advance driving sales growth.
- Strong surgeon adoption supported by marketing investments.
- A$6.6 million capital raise completed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$4,745 |
Change of Director's Interest Notice - D Goodin
|
26 Feb 2025 9:12AM |
$35.750 |
$32.510 |
fallen by
9.06%
|
|
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,174 |
Update - Notification of buy-back - ABB
|
26 Feb 2025 9:12AM |
$3.740 |
$3.970 |
risen by
6.15%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$36 |
Half Yearly Report and Accounts
|
26 Feb 2025 9:12AM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax of $5,394,000 for the half-year ending December 31, 2024
- Improvement from previous year's loss of $5,625,000
- 27% increase in sales revenue to $12,925,000
- EBITDA loss of $4,237,000 compared to $4,190,000 in the prior period
- Growth driven by the Glaucoma Surgical Devices segment in the USA
- Challenges remain due to production cost increases and supply chain issues
- Company plans to raise $6.6 million through a share placement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maximus Resources Limited (MXR) ORDINARY FULLY PAID |
Materials |
$33 |
Change in substantial holding from AAR
|
26 Feb 2025 9:11AM |
$0.064 |
$0.077 |
risen by
20.31%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$213 |
Change in substantial holding for MXR
|
26 Feb 2025 9:11AM |
$0.135 |
$0.150 |
risen by
11.11%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
